Release Testing Criteria
Release Testing Criteria is a regulatory quality control framework that specifies the minimum standards and analytical requirements a gene therapy product must meet prior to release for clinical use, distinguishing it from other regulatory assessments by focusing exclusively on batch-specific safety, purity, potency, and identity attributes verified through validated testing methods.
10
Publications
272
Citations
57
Authors
25
Institutions
Publications per year
2017–2026
2
10
Chantal Lechanteur · Journal of Stem Cell Research & Therapy · 2014 · 49 citations · Full text
Danielle I. Stanisic, Xue Q. Liu, Sai Lata De et al. · Malaria Journal · 2015 · 46 citations · Full text
Gina R. Rayat, Lawrence S. Gazda, Wayne J. Hawthorne et al. · Xenotransplantation · 2016 · 25 citations
1–5 of 10
57
1
h-index
National Institutes of Health Clinical Center, United States
1 publications · 21 citations
1
h-index
1
h-index
1
h-index
1
h-index
1–5 of 57
25
University of California, Berkeley
Berkeley, United States
1 h-index
4 publications
120 citations

Mendel University in Brno
Brno, Czechia
1 h-index
1 publications
16 citations

The University of Sydney
Sydney, Australia
1 h-index
1 publications
25 citations
National Institutes of Health Clinical Center
Bethesda, United States
1 h-index
9 publications
189 citations
Institute of Radiotherapy and Nuclear Medicine
Peshawar, Pakistan
1 h-index
1 publications
14 citations
QIMR Berghofer Medical Research Institute
Brisbane, Australia
1 h-index
4 publications
184 citations

Griffith University
Brisbane, Australia
1 h-index
7 publications
322 citations

Auckland Council
Auckland, New Zealand
1 h-index
1 publications
25 citations
1–8 of 25
1 publications · 14 citations
1
h-index
1 publications · 19 citations
1
h-index
1 publications · 46 citations
1
h-index
1 publications · 20 citations
1
h-index
1 publications · 30 citations
1
h-index
1–5